Bafna Pharmaceuticals Ltd.

Market Capital
₹283 Cr.
P/E
24.95
Share Price
₹ 119.6 5.65 (4.96%)

Bafna Pharmaceuticals Ltd.

Quick View
₹ 119.6 5.65 (4.96%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Other Income
Other Income is not affecting ratios of the company
Pledge
Promoters have not pledged a significant portion of their holding
Debt
Company might have issues servicing its debt
Current vs Historic Valuation
Company is trading at a discount to 3yr historic valuations
Working Capital
Working Capital of the company seems to be under control
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Capex vs ROCE
ROCE of the company has increased over the last three years
Share price
Share price has increased over last 10 years due to earnings
Contingent Liabilities
Company does not have significant contingent liabilities
Promoter Holding
Promoter has not sold any shares in the last 90 days
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
ROE
Latest
8.19%
3yr Average
-9.97%
5yr Average
-34.61%
Net Profit Margin
Latest
6.05%
3yr Average
-14.66%
5yr Average
-24.55%
ROCE
Latest
10.97%
3yr Average
6.08%
5yr Average
-4.98%
Debt to Equity
Latest
0.14
3yr Average
0.14
5yr Average
0.82
Company Filing
Show Previous Years
Discussions & Analysis
timeline
Sign Up for Free